Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immuron Limited - American Depositary Shares (NQ:IMRN)

0.8600 +0.0071 (+0.83%)
Delayed Quote Updated: 9:52 AM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Immuron Limited - American Depositary Shares

< Previous 1 2 3 4 Next >
News headline image
Emerging Growth Research Reports Continued Revenue Growth at Immuron
From Immuron Limited
Via ACCESS Newswire
News headline image
Immuron continued quarterly sales growth
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore presentation at Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
News headline image
Travelan® Phase 2 Study Results Published
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron to launch PROIBS® in the United States
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Reports FY26 Preliminary Results
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
From Immuron Limited
Via GlobeNewswire
News headline image
Emerging Growth Research Releases Flash Report on Immuron; Maintains Buy-Extended Rating and Raises Price Target to $4.00
Via ACCESS Newswire
News headline image
Immuron Double Digit 3Q Sales Growth
From Immuron Limited
Via GlobeNewswire
News headline image
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target
Via ACCESS Newswire
News headline image
Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Reports HY26 Results and Strategic Reset
From Immuron Limited
Via GlobeNewswire
News headline image
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target
Via ACCESS Newswire
News headline image
Immuron Reports Continued Sales Growth
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron New U.S. Department of Defense Award & Clinical Trial Update
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron IMM-529 IND approved by FDA
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Announces Clinical Trial Update
From Immuron Limited
Via GlobeNewswire
News headline image
Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target
New York, New York--(Newsfile Corp. - October 17, 2025) - Emerging Growth Research today announced the initiation of coverage on... 
Via Newsfile
News headline image
Immuron Q1 FY26 YoY growth
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Submits IMM-529 IND to FDA
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Letter to Shareholders – Projects Update
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron partners with InvestorHub
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron - FY25 global sales exceed projection, up 49% on prior year
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Letter to Shareholders: Projects Update
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Travelan® highest sales in history
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Travelan® continued strong sales growth
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
From Immuron Limited
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.